These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 22020938)

  • 1. Importin β1 protein-mediated nuclear localization of death receptor 5 (DR5) limits DR5/tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced cell death of human tumor cells.
    Kojima Y; Nakayama M; Nishina T; Nakano H; Koyanagi M; Takeda K; Okumura K; Yagita H
    J Biol Chem; 2011 Dec; 286(50):43383-93. PubMed ID: 22020938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Importin β1 Augments the Anticancer Effect of Agonistic Anti-Death Receptor 5 Antibody in TRAIL-resistant Tumor Cells.
    Kojima Y; Nishina T; Nakano H; Okumura K; Takeda K
    Mol Cancer Ther; 2020 May; 19(5):1123-1133. PubMed ID: 32156787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
    Yasuda T; Yoshida T; Goda AE; Horinaka M; Yano K; Shiraishi T; Wakada M; Mizutani Y; Miki T; Sakai T
    Mol Cancer Res; 2008 Dec; 6(12):1852-60. PubMed ID: 19074830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting KPNB1 overcomes TRAIL resistance by regulating DR5, Mcl-1 and FLIP in glioblastoma cells.
    Zhu ZC; Liu JW; Yang C; Li MJ; Wu RJ; Xiong ZQ
    Cell Death Dis; 2019 Feb; 10(2):118. PubMed ID: 30742128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The herbal compound cryptotanshinone restores sensitivity in cancer cells that are resistant to the tumor necrosis factor-related apoptosis-inducing ligand.
    Tse AK; Chow KY; Cao HH; Cheng CY; Kwan HY; Yu H; Zhu GY; Wu YC; Fong WF; Yu ZL
    J Biol Chem; 2013 Oct; 288(41):29923-33. PubMed ID: 23986445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GDP-mannose-4,6-dehydratase (GMDS) deficiency renders colon cancer cells resistant to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor- and CD95-mediated apoptosis by inhibiting complex II formation.
    Moriwaki K; Shinzaki S; Miyoshi E
    J Biol Chem; 2011 Dec; 286(50):43123-33. PubMed ID: 22027835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.
    Maduro JH; de Vries EG; Meersma GJ; Hougardy BM; van der Zee AG; de Jong S
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):543-52. PubMed ID: 18793956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK
    Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Death receptor 5 is activated by fucosylation in colon cancer cells.
    Zhang B; van Roosmalen IAM; Reis CR; Setroikromo R; Quax WJ
    FEBS J; 2019 Feb; 286(3):555-571. PubMed ID: 30589515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of activating transcription factor 3 (ATF3) in endoplasmic reticulum (ER) stress-induced sensitization of p53-deficient human colon cancer cells to tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through up-regulation of death receptor 5 (DR5) by zerumbone and celecoxib.
    Edagawa M; Kawauchi J; Hirata M; Goshima H; Inoue M; Okamoto T; Murakami A; Maehara Y; Kitajima S
    J Biol Chem; 2014 Aug; 289(31):21544-61. PubMed ID: 24939851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular localization of DR5 and related regulatory pathways as a mechanism of resistance to TRAIL in cancer.
    Mert U; Sanlioglu AD
    Cell Mol Life Sci; 2017 Jan; 74(2):245-255. PubMed ID: 27510421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK-mediated DR5 regulation in colorectal cancer.
    Kim SL; Min IS; Park YR; Lee ST; Kim SW
    Int J Oncol; 2018 Dec; 53(6):2789-2799. PubMed ID: 30221676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation.
    Kim IY; Kang YJ; Yoon MJ; Kim EH; Kim SU; Kwon TK; Kim IA; Choi KS
    Neuro Oncol; 2011 Mar; 13(3):267-79. PubMed ID: 21292685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells.
    Taniguchi H; Yoshida T; Horinaka M; Yasuda T; Goda AE; Konishi M; Wakada M; Kataoka K; Yoshikawa T; Sakai T
    Cancer Res; 2008 Nov; 68(21):8918-27. PubMed ID: 18974136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Acetyl-Glucosamine Sensitizes Non-Small Cell Lung Cancer Cells to TRAIL-Induced Apoptosis by Activating Death Receptor 5.
    Liang Y; Xu W; Liu S; Chi J; Zhang J; Sui A; Wang L; Liang Z; Li D; Chen Y; Niu H
    Cell Physiol Biochem; 2018; 45(5):2054-2070. PubMed ID: 29533936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation.
    Kim EH; Yoon MJ; Kim SU; Kwon TK; Sohn S; Choi KS
    Cancer Res; 2008 Jan; 68(1):266-75. PubMed ID: 18172319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caudatin potentiates the anti-tumor effects of TRAIL against human breast cancer by upregulating DR5.
    Fei HR; Yuan C; Wang GL; Zhao Y; Li ZJ; Du X; Wang FZ
    Phytomedicine; 2019 Sep; 62():152950. PubMed ID: 31102888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of proapoptotic anticancer therapeutic response in vivo based on cell death visualization and TRAIL death ligand-receptor interaction.
    Zhou L; Wang W; Dicker DT; Humphreys RC; El-Deiry WS
    Cancer Biol Ther; 2011 Aug; 12(4):335-48. PubMed ID: 21785270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1.
    Baritaki S; Huerta-Yepez S; Sakai T; Spandidos DA; Bonavida B
    Mol Cancer Ther; 2007 Apr; 6(4):1387-99. PubMed ID: 17431117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation in the targeting of TRAIL receptor 1 to cell surface via GODZ for TRAIL sensitivity in tumor cells.
    Oh Y; Jeon YJ; Hong GS; Kim I; Woo HN; Jung YK
    Cell Death Differ; 2012 Jul; 19(7):1196-207. PubMed ID: 22240897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.